Clinical Trial Update: Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study [Phase 1]

View source ↗

Summary

Phase 1 investigational safety study of intravitreal ketorolac for chronic uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Vanderbilt University | Conditions: Inflammation | Phase 1 | Status: COMPLETED